| 【Company Research】Futu Holdings (FUTU US) - Strong 2Q beat; overseas expansion gains full momentum |
| 【公司研究】中国生物制药 (1177 HK) - BD集中兑现，平台创新价值获验证 |
| 【Company Research】United Imaging (688271 CH) - Robust overseas growth offset soft domestic demand |
| 【Company Research】Alibaba (BABA US) - Strong cloud growth prospects with clear ROIC visibility |
| 【Company Research】NetEase (NTES US) - 2Q26 earnings beat; legacy game titles maintain solid performance |
| 【行业研究】26年2季度美股13F追踪 - 盈利增长与估值匹配视角下科技板块或仍具较高配置价值 |
| 【Company Research】AIA Group Ltd. (1299 HK) - 1H26 first take: VONB largely in line; OPAT lift a slight beat, with no additional 2H26 buyback |
| 【Company Research】Xunfei Healthcare (2506 HK) - Robust 1H26 performance driven by AI Health Partner |
| 【Company Research】Guoquan Food (2517 HK) - Expect slower store expansion with broader revenue support |
| 【Company Research】Kuaishou (1024 HK) - 2Q26 review: Challenging environment; AI monetization on track |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
